Login
$IXHL
$2.58 -$0.13 (4.8%) Close

Insider Transactions

What Incannex Healthcare Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 0
Sells 0 0
Total trades 0 6

Shares traded

3 months 12 months
Acquired 0 0
Disposed 0 0
Net activity +0 +0

Common stock only — 6 reported trades in the last 12 months are in a security these totals do not cover.

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Clark Robert Director Nov 14 Grant / award · A +1,686,956 — — 1,786,956
Valentine Troy Director Nov 14 Grant / award · A +11,302,608 — — 12,001,858
Anastassov George Director Nov 14 Grant / award · A +1,686,956 — — 2,456,677
Latham Joel CEO and President Nov 14 Grant / award · A +22,608,692 — — 24,186,177
Swan Joseph CFO, Treasurer and Secretary Nov 14 Grant / award · A +869,565 — — 921,358
Widdows Peter Director Nov 14 Grant / award · A +1,686,956 — — 1,957,803
Barbato Luigi M. Chief Medical Officer Oct 23 Grant / award · A +100,476 — — 100,476
Swan Joseph CFO, Treasurer and Secretary May 06 Grant / award · A +50,793 — — 51,793
Clark Robert Director Dec 21 Grant / award · A +100,000 — — 100,000
Valentine Troy Director Dec 21 Grant / award · A +670,000 — — 699,250
Anastassov George Director Dec 21 Grant / award · A +100,000 — — 769,721
Latham Joel CEO and President Dec 21 Grant / award · A +1,340,000 — — 1,577,485
Widdows Peter Director Dec 21 Grant / award · A +100,000 — — 270,847

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support